These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 18367347)
1. Multiple symmetric lipomatosis - a reflection of new concepts about obesity. Pandzic Jaksic V; Sucic M Med Hypotheses; 2008; 71(1):99-101. PubMed ID: 18367347 [TBL] [Abstract][Full Text] [Related]
2. Multiple symmetric lipomatosis. Ultrastructural investigation of the tissue and preadipocytes in primary culture. Zancanaro C; Sbarbati A; Morroni M; Carraro R; Cigolini M; Enzi G; Cinti S Lab Invest; 1990 Aug; 63(2):253-8. PubMed ID: 2381166 [TBL] [Abstract][Full Text] [Related]
3. [Multiple symmetrical lipomatosis (MSL): a clinical case and a review of the literature]. Lomartire N; Ciocca F; Di Stanislao C; Bologna G; Giuliani M Ann Ital Chir; 1999; 70(2):259-62; discussion 262-3. PubMed ID: 10434460 [TBL] [Abstract][Full Text] [Related]
4. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995 [TBL] [Abstract][Full Text] [Related]
6. Multiple symmetric lipomatosis type 2 in females--report of two cases. Pandzić Jaksić V; Stoos Veić T Acta Dermatovenerol Croat; 2008; 16(1):31-4. PubMed ID: 18358107 [TBL] [Abstract][Full Text] [Related]
7. Multiple symmetric lipomatosis: clinical aspects and outcome in a long-term longitudinal study. Enzi G; Busetto L; Ceschin E; Coin A; Digito M; Pigozzo S Int J Obes Relat Metab Disord; 2002 Feb; 26(2):253-61. PubMed ID: 11850759 [TBL] [Abstract][Full Text] [Related]
8. [Multiple symmetrical lipomatosis and chronic alcoholism]. Grau Martín A; González-Huix F; Ricart Engel W; Masabeu Urrutia M; Acero Fernández D; Soler Simón S An Med Interna; 1989 Dec; 6(12):635-8. PubMed ID: 2491474 [TBL] [Abstract][Full Text] [Related]
9. MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue. Capel E; Vatier C; Cervera P; Stojkovic T; Disse E; Cottereau AS; Auclair M; Verpont MC; Mosbah H; Gourdy P; Barraud S; Miquel A; Züchner S; Bonnefond A; Froguel P; Christin-Maitre S; Delemer B; Fève B; Laville M; Robert J; Tenenbaum F; Lascols O; Vigouroux C; Jéru I J Clin Lipidol; 2018; 12(6):1420-1435. PubMed ID: 30158064 [TBL] [Abstract][Full Text] [Related]
10. [Multiple symmetrical lipomatosis. Metabolic effects of excision of lipomatous tissue]. Melga P; Buzzo P; Accoto S; Cheli V; Prando R Riv Eur Sci Med Farmacol; 1993; 15(1):11-5. PubMed ID: 8159830 [TBL] [Abstract][Full Text] [Related]
11. Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity. Hemmrich K; Thomas GP; Abberton KM; Thompson EW; Rophael JA; Penington AJ; Morrison WA Obesity (Silver Spring); 2007 Dec; 15(12):2951-7. PubMed ID: 18198303 [TBL] [Abstract][Full Text] [Related]
12. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061 [TBL] [Abstract][Full Text] [Related]
13. Multiple symmetric lipomatosis: an unusual cause of childhood obesity and mental retardation. Kratz C; Lenard HG; Ruzicka T; Gärtner J Eur J Paediatr Neurol; 2000; 4(2):63-7. PubMed ID: 10817486 [TBL] [Abstract][Full Text] [Related]
14. miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis. Chen K; He H; Xie Y; Zhao L; Zhao S; Wan X; Yang W; Mo Z Sci Rep; 2015 Jul; 5():11909. PubMed ID: 26148871 [TBL] [Abstract][Full Text] [Related]
15. Multiple symmetric lipomatosis: a rare disease and its possible links to brown adipose tissue. Enzi G; Busetto L; Sergi G; Coin A; Inelmen EM; Vindigni V; Bassetto F; Cinti S Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):347-53. PubMed ID: 25770761 [TBL] [Abstract][Full Text] [Related]
16. Benign symmetric lipomatosis in a 73-year-old man: a case report with a brief review of the literature. Kise Y; Shimoji M; Toda T; Kiyuna M; Iwasaki H Rinsho Byori; 2004 Oct; 52(10):824-7. PubMed ID: 15624498 [TBL] [Abstract][Full Text] [Related]
17. Differential clinical expression of multiple symmetric lipomatosis in men and women. Busetto L; Sträter D; Enzi G; Coin A; Sergi G; Inelmen EM; Pigozzo S Int J Obes Relat Metab Disord; 2003 Nov; 27(11):1419-22. PubMed ID: 14574355 [TBL] [Abstract][Full Text] [Related]
18. Calcyphosine-like (CAPSL) is regulated in Multiple Symmetric Lipomatosis and is involved in Adipogenesis. Lindner A; Marbach F; Tschernitz S; Ortner C; Berneburg M; Felthaus O; Prantl L; Kye MJ; Rappl G; Altmüller J; Thiele H; Schreml S; Schreml J Sci Rep; 2019 Jun; 9(1):8444. PubMed ID: 31186450 [TBL] [Abstract][Full Text] [Related]
19. Multiple symmetric lipomatosis: substantial subcutaneous adipose tissue accumulation did not induce glucose and lipid metabolism dysfunction. Chen K; Xie Y; Hu P; Zhao S; Mo Z Ann Nutr Metab; 2010; 57(1):68-73. PubMed ID: 20714139 [TBL] [Abstract][Full Text] [Related]